Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Inflammatory Process”

57 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 57 results

Large-scale testing (Phase 3)UnknownNCT05443854
What this trial is testing

Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01)

Who this might be right for
SepsisSeptic ShockHematologic Malignancy+2 more
Assistance Publique - Hôpitaux de Paris 340
Not applicableUnknownNCT02589535
What this trial is testing

Circulating Stem Cells, SDF-1, HIF-1 and Sepsis's Indices in Emergency Abdominal Surgical Patients

Who this might be right for
Sepsis
University of Foggia 66
Large-scale testing (Phase 3)Ended earlyNCT04371393
What this trial is testing

MSCs in COVID-19 ARDS

Who this might be right for
Mesenchymal Stromal CellsRemestemcel-LAcute Respiratory Distress Syndrome+1 more
Icahn School of Medicine at Mount Sinai 223
Early research (Phase 1)Ended earlyNCT04961658
What this trial is testing

Advanced Mesenchymal Enhanced Cell THerapY for SepTic Patients

Who this might be right for
Septic Shock
Northern Therapeutics 11
Not applicableUnknownNCT03913403
What this trial is testing

Study of Treatment's Echocardiographic Mechanisms

Who this might be right for
Sepsis
Intermountain Health Care, Inc. 210
Large-scale testing (Phase 3)UnknownNCT05216562
What this trial is testing

Efficacy and Safety of EXOSOME-MSC Therapy to Reduce Hyper-inflammation In Moderate COVID-19 Patients

Who this might be right for
SARS-CoV2 Infection
Dermama Bioteknologi Laboratorium 60
Not applicableUnknownNCT06022445
What this trial is testing

Prospective Validation of CARPET Prognostic Model for Septic Shock After Allo-HSCT

Who this might be right for
Stem Cell Transplant Complications
Peking University People's Hospital 200
Not applicableNot Yet RecruitingNCT07425587
What this trial is testing

Multicenter Symphony™ IL-6 Monitoring Sepsis ED Pilot Study

Who this might be right for
Sepsis, Septic Shock
Bluejay Diagnostics, Inc. 450
Not applicableLooking for participantsNCT02545478
What this trial is testing

Biomarkers in Infection

Who this might be right for
SepsisInfectionInflammation
Beth Israel Deaconess Medical Center 4,200
Testing effectiveness (Phase 2)UnknownNCT03369275
What this trial is testing

Cellular Immunotherapy for Septic Shock

Who this might be right for
Septic ShockSepsisPathologic Processes+4 more
Ottawa Hospital Research Institute 114
Post-approval studies (Phase 4)Ended earlyNCT04673175
What this trial is testing

Ceftolozane-Tazobactam for Directed Treatment of Pseudomonas Aeruginosa Bacteremia and Pneumonia in Patients With Hematological Malignancies and Hematopoietic Stem Cell Transplantation

Who this might be right for
PneumoniaHematologic MalignancyPseudomonas Aeruginosa Infection+2 more
Weill Medical College of Cornell University 17
Not applicableStudy completedNCT01351805
What this trial is testing

Vitamin D and Fish Oil for Autoimmune Disease, Inflammation and Knee Pain

Who this might be right for
Autoimmune DiseasesSystemic Inflammatory ProcessKnee Pain Chronic+2 more
Brigham and Women's Hospital 25,871
Testing effectiveness (Phase 2)Study completedNCT02759731
What this trial is testing

Study of Baricitinib, a JAK1/2 Inhibitor, in Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Chronic Graft vs Host DiseaseChronic Graft-Versus-Host Disease
National Cancer Institute (NCI) 24
Post-approval studies (Phase 4)Study completedNCT00067730
What this trial is testing

A Safety Evaluation of Drotrecogin Alfa (Activated) in Patients With Blood Cancer, Severe Infection Related to Bone Marrow Transplantation

Who this might be right for
SepsisHematologic NeoplasmsHematopoietic Stem Cell Transplantation+1 more
Eli Lilly and Company 7
Testing effectiveness (Phase 2)UnknownNCT04781803
What this trial is testing

Cyclosporine on Day Zero as Prophylaxis for Cytokine Release Syndrome

Who this might be right for
Stem Cell Transplant ComplicationsCytokine Release Syndrome
Hospital Universitario Dr. Jose E. Gonzalez 32
Not applicableLooking for participantsNCT05191381
What this trial is testing

Immune Modulation by Exosomes in COVID-19

Who this might be right for
COVID-19Critical IllnessHypercytokinemia+1 more
University of Ulm 40
Not applicableStudy completedNCT02789995
What this trial is testing

Dysfunctions of Human Muscle Stem Cells in Sepsis

Who this might be right for
Sepsis
Institut Pasteur 93
Not applicableUnknownNCT02883803
What this trial is testing

Treatment of Severe Infections With Mesenchymal Stem Cells

Who this might be right for
Septic Shock
Central Hospital, Nancy, France 66
Testing effectiveness (Phase 2)UnknownNCT04533464
What this trial is testing

MultiStem® for Treatment of Trauma Induced Multiple Organ Failure/Systemic Inflammatory Response Syndrome

Who this might be right for
TraumaAdult Stem Cells
Healios K.K. 156
Testing effectiveness (Phase 2)Looking for participantsNCT01962415
What this trial is testing

Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT

Who this might be right for
Primary Immunodeficiency (PID)Congenital Bone Marrow Failure SyndromesInherited Metabolic Disorders (IMD)+4 more
Paul Szabolcs 100
Load More Results